Redgrove Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-12-2024
- Paid Up Capital ₹ 0.10 M
as on 27-12-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 276.61%
(FY 2021)
- Profit 206.28%
(FY 2021)
- Ebitda 224.97%
(FY 2021)
- Net Worth 243.05%
(FY 2021)
- Total Assets 46.10%
(FY 2021)
About Redgrove Pharmaceuticals India
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Avni Shah and Firuzi Langrana serve as directors at the Company.
- CIN/LLPIN
U74999MH2019FTC325669
- Company No.
325669
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
22 May 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Redgrove Pharmaceuticals India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avni Shah  | Additional Director | 24-Mar-2024 | Current |
| Firuzi Langrana | Director | 22-May-2019 | Current |
Financial Performance of Redgrove Pharmaceuticals India.
Redgrove Pharmaceuticals India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 276.61% increase. The company also saw a substantial improvement in profitability, with a 206.28% increase in profit. The company's net worth Soared by an impressive increase of 243.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Redgrove Pharmaceuticals India?
In 2021, Redgrove Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ts Brass And Bronze Works Private LimitedActive 6 years 1 monthAvni Shah and Firuzi Langrana are mutual person
Pp Processing Services India Private LimitedActive 8 years 3 monthsAvni Shah and Firuzi Langrana are mutual person
Virtuosgames Studios Private LimitedActive 10 months 12 daysAvni Shah and Firuzi Langrana are mutual person
- Dsilo Ai Technologies Private LimitedInactive For E-Filing 7 months 28 days
Avni Shah and Firuzi Langrana are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Redgrove Pharmaceuticals India?
Unlock and access historical data on people associated with Redgrove Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Redgrove Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redgrove Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
